search
Company Information
USD
107.76
- (-1%)
NASDAQ:AXSM, AXSOME THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Address

One World Trade Center
22nd Floor

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Mark E. Saad
Director
Dr. Roger A. Jeffs, PhD
Director
Dr. Susan Mahony, M.B.A.,PhD
Director
Dr. Herriot Tabuteau, M.D.
CEO/Chairman of the Board/Director/Founder/President
Dr. Mark Coleman, M.D.
Director
Mr. Nick Pizzie
CFO/Chief Accounting Officer
Mr. Mark Jacobson, M.A.
COO
Ms. Lori Englebert
Executive VP, Divisional
Mr. Hunter Murdock
General Counsel

Ownership

Institution Holdings

RTW INVESTMENTS, LLC
4,489,596 (9.477%)
Vanguard Group Inc
3,696,766 (7.803%)
BlackRock Inc
3,239,746 (6.839%)
Fairmount Funds Management LLC
2,360,077 (4.982%)
Bvf Inc
2,131,100 (4.498%)
BlackRock Fund Advisors
1,684,370 (3.555%)
PFM Health Sciences, LP
1,391,831 (2.941%)
Citadel Advisors Llc
1,295,624 (2.735%)
Vanguard Investments Australia Ltd
1,200,156 (2.533%)
Perceptive Advisors LLC
1,038,019 (2.191%)

Individual Holdings

Dr. Roger A. Jeffs, PhD
120,756 (0.320%)
Mr. Nick Pizzie
41,789 (0.111%)
Dr. Mark Coleman, M.D.
25,097 (0.053%)
Dr. Herriot Tabuteau, M.D.
7,229 (0.038%)
Mr. Mark E. Saad
10,002 (0.027%)

Funds Holdings

Vanguard Total Stock Market Index Fund
1,193,164 (2.519%)
Vanguard US Total Market Shares ETF
1,193,164 (2.519%)
Vanguard Small Cap Index
966,726 (2.041%)
iShares Russell 2000 ETF
873,606 (1.844%)
Vanguard Institutional Extnd Mkt Idx Tr
571,450 (1.206%)
Vanguard Small Cap Growth Index Fund
540,117 (1.140%)
Fidelity Small Cap Index Fund
355,048 (0.749%)
Pictet - Biotech
325,131 (0.686%)
iShares Russell 2000 Growth ETF
313,399 (0.662%)
iShares Biotechnology ETF
295,512 (0.624%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices